Recombinant Monovalent Llama-Derived Antibody Fragments (VHH) to Rotavirus VP6 Protect Neonatal Gnotobiotic Piglets against Human Rotavirus-Induced Diarrhea

被引:60
作者
Vega, Celina G. [1 ]
Bok, Marina [1 ]
Vlasova, Anastasia N. [2 ]
Chattha, Kuldeep S. [2 ]
Gomez-Sebastian, Silvia [3 ]
Nunez, Carmen [3 ]
Alvarado, Carmen [3 ]
Lasa, Rodrigo [3 ]
Escribano, Jose M. [4 ]
Garaicoechea, Lorena L. [1 ]
Fernandez, Fernando [1 ]
Bok, Karin [5 ]
Wigdorovitz, Andres [1 ]
Saif, Linda J. [2 ]
Parreno, Viviana [1 ]
机构
[1] INTA Castelar, Ctr Invest Ciencias Vet & Agron, Inst Virol, Buenos Aires, DF, Argentina
[2] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA
[3] Univ Politecn Madrid, Alternat Gene Express SL ALGENEX, Ctr Empresarial Parque Cient & Tecnol, Madrid, Spain
[4] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain
[5] NIAID, Caliciviruses Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
FED COLOSTRUM SUPPLEMENTS; VIRUS-LIKE PARTICLES; IMMUNE-RESPONSES; BOVINE ROTAVIRUS; MONOCLONAL-ANTIBODIES; NEUTRALIZING ACTIVITY; VACCINATION PROGRAMS; MATERNAL ANTIBODIES; NASAL IMMUNIZATION; CONFER PROTECTION;
D O I
10.1371/journal.ppat.1003334
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Group A Rotavirus (RVA) is the leading cause of severe diarrhea in children. The aims of the present study were to determine the neutralizing activity of VP6-specific llama-derived single domain nanoantibodies (VHH nanoAbs) against different RVA strains in vitro and to evaluate the ability of G6P[1] VP6-specific llama-derived single domain nanoantibodies (VHH) to protect against human rotavirus in gnotobiotic (Gn) piglets experimentally inoculated with virulent Wa G1P[8] rotavirus. Supplementation of the daily milk diet with 3B2 VHH clone produced using a baculovirus vector expression system (final ELISA antibody -Ab- titer of 4096; virus neutralization -VN- titer of 256) for 9 days conferred full protection against rotavirus associated diarrhea and significantly reduced virus shedding. The administration of comparable levels of porcine IgG Abs only protected 4 out of 6 of the animals from human RVA diarrhea but significantly reduced virus shedding. In contrast, G6P[1]-VP6 rotavirus-specific IgY Abs purified from eggs of hyperimmunized hens failed to protect piglets against human RVA-induced diarrhea or virus shedding when administering similar quantities of Abs. The oral administration of VHH nanoAb neither interfered with the host's isotype profiles of the Ab secreting cell responses to rotavirus, nor induced detectable host Ab responses to the treatment in serum or intestinal contents. This study shows that the oral administration of rotavirus VP6-VHH nanoAb is a broadly reactive and effective treatment against rotavirus-induced diarrhea in neonatal pigs. Our findings highlight the potential value of a broad neutralizing VP6-specific VHH nanoAb as a treatment that can complement or be used as an alternative to the current strain-specific RVA vaccines. Nanobodies could also be scaled-up to develop pediatric medication or functional food like infant milk formulas that might help treat RVA diarrhea.
引用
收藏
页数:17
相关论文
共 91 条
[1]   Evaluation of allergenicity of egg yolk immunoglobulin Y and other egg proteins by passive cutaneous anaphylaxis [J].
Akita, EM ;
Jang, CB ;
Kitts, DD ;
Nakai, S .
FOOD AND AGRICULTURAL IMMUNOLOGY, 1999, 11 (02) :191-201
[2]   In Vitro Neutralisation of Rotavirus Infection by Two Broadly Specific Recombinant Monovalent Llama-Derived Antibody Fragments [J].
Aladin, Farah ;
Einerhand, Alexandra W. C. ;
Bouma, Janneke ;
Bezemer, Sandra ;
Hermans, Pim ;
Wolvers, Danielle ;
Bellamy, Kate ;
Frenken, Leon G. J. ;
Gray, Jim ;
Iturriza-Gomara, Miren .
PLOS ONE, 2012, 7 (03)
[3]   Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease [J].
Alonso-Padilla, Julio ;
Jimenez de Oya, Nereida ;
Blazquez, Ana-Belen ;
Escribano-Romero, Estela ;
Escribano, Jose M. ;
Saiz, Juan-Carlos .
VACCINE, 2011, 29 (09) :1830-1835
[4]   Rotavirus infection in adults [J].
Anderson, EJ ;
Weber, SG .
LANCET INFECTIOUS DISEASES, 2004, 4 (02) :91-99
[5]  
[Anonymous], 1999, BOOK MULTIPLE COMP M
[6]   Rotavirus vaccination in developing countries [J].
Babji, Sudhir ;
Kang, Gagandeep .
CURRENT OPINION IN VIROLOGY, 2012, 2 (04) :443-448
[7]   Global, regional, and national causes of child mortality in 2008: a systematic analysis [J].
Black, Robert E. ;
Cousens, Simon ;
Johnson, Hope L. ;
Lawn, Joy E. ;
Rudan, Igor ;
Bassani, Diego G. ;
Jha, Prabhat ;
Campbell, Harry ;
Walker, Christa Fischer ;
Cibulskis, Richard ;
Eisele, Thomas ;
Liu, Li ;
Mathers, Colin .
LANCET, 2010, 375 (9730) :1969-1987
[8]   Genotype Diversity of Group A Rotavirus Strains in Children With Acute Diarrhea in Urban Burkina Faso, 2008-2010 [J].
Bonkoungou, Isidore J. O. ;
Damanka, Susan ;
Sanou, Idrissa ;
Tiendrebeogo, Fidele ;
Coulibaly, Sheick O. ;
Bon, Fabienne ;
Haukka, Kaisa ;
Traore, Alfred S. ;
Barro, Nicolas ;
Armah, George E. .
JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (08) :1485-1490
[9]   Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity [J].
Burns, JW ;
SiadatPajouh, M ;
Krishnaney, AA ;
Greenberg, HB .
SCIENCE, 1996, 272 (5258) :104-107
[10]  
(CDC) CfDCaP, 2010, MORBIDITY MORTALITY